Literature DB >> 31656810

Tumor location does not limit percutaneous treatment of small renal masses with microwave ablation.

Xiaosong Meng1, Rashed Ghandour1, Vitaly Margulis1.   

Abstract

Year:  2019        PMID： 31656810      PMCID： PMC6789320          DOI： 10.21037/atm.2019.08.70

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  22 in total

1.  Single-center comparative oncologic outcomes of surgical and percutaneous cryoablation for treatment of renal tumors.

Authors:  Jatinder Goyal; Payal Verma; Abhinav Sidana; Christos S Georgiades; Ronald Rodriguez
Journal:  J Endourol       Date:  2012-11       Impact factor: 2.942

2.  Thermal Ablation of T1c Renal Cell Carcinoma: A Comparative Assessment of Technical Performance, Procedural Outcome, and Safety of Microwave Ablation, Radiofrequency Ablation, and Cryoablation.

Authors:  Wenhui Zhou; Ronald S Arellano
Journal:  J Vasc Interv Radiol       Date:  2018-04-06       Impact factor: 3.464

3.  A comparison of microwave ablation and bipolar radiofrequency ablation both with an internally cooled probe: results in ex vivo and in vivo porcine livers.

Authors:  Jie Yu; Ping Liang; Xiaoling Yu; Fangyi Liu; Lei Chen; Yang Wang
Journal:  Eur J Radiol       Date:  2010-01-04       Impact factor: 3.528

4.  Ablative therapies: Advantages and disadvantages of radiofrequency, cryotherapy, microwave and electroporation methods, or how to choose the right method for an individual patient?

Authors:  O Seror
Journal:  Diagn Interv Imaging       Date:  2015-05-14       Impact factor: 4.026

5.  Percutaneous radiofrequency ablation of small renal tumors using CT-guidance: a review and its current role.

Authors:  Richard L Haddad; Manish I Patel; Philip Vladica; Wassim Kassouf; Frank Bladou; Maurice Anidjar
Journal:  Urol J       Date:  2012       Impact factor: 1.510

Review 6.  Microwave tumor ablation: mechanism of action, clinical results, and devices.

Authors:  Meghan G Lubner; Christopher L Brace; J Louis Hinshaw; Fred T Lee
Journal:  J Vasc Interv Radiol       Date:  2010-08       Impact factor: 3.464

7.  Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older.

Authors:  Brian R Lane; Robert Abouassaly; Tianming Gao; Christopher J Weight; Adrian V Hernandez; Benjamin T Larson; Jihad H Kaouk; Inderbir S Gill; Steven C Campbell
Journal:  Cancer       Date:  2010-07-01       Impact factor: 6.860

8.  Cancer statistics, 2015.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-01-05       Impact factor: 508.702

9.  Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation.

Authors:  Thomas D Atwell; Grant D Schmit; Stephen A Boorjian; Jay Mandrekar; A Nicholas Kurup; Adam J Weisbrod; George K Chow; Bradley C Leibovich; Matthew R Callstrom; David E Patterson; Christine M Lohse; R Houston Thompson
Journal:  AJR Am J Roentgenol       Date:  2013-02       Impact factor: 3.959

10.  Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.

Authors:  R Houston Thompson; Tom Atwell; Grant Schmit; Christine M Lohse; A Nicholas Kurup; Adam Weisbrod; Sarah P Psutka; Suzanne B Stewart; Matthew R Callstrom; John C Cheville; Stephen A Boorjian; Bradley C Leibovich
Journal:  Eur Urol       Date:  2014-08-06       Impact factor: 20.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.